Status:
UNKNOWN
Handwritten Text Production in Adults With Autism
Lead Sponsor:
Centre Hospitalier de Niort
Collaborating Sponsors:
University of Poitiers
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main objective is to assess the psycholinguistic and graphomotor characteristics of written production in patients with ASD. The secondary objectives are: * Identifying links between specific de...
Detailed Description
Context : Autism Spectrum Disorder (ASD) is one of the neurodevelopmental disorders (NDD) characterized by persistent deficits in communication and social interaction, and restricted and repetitive p...
Eligibility Criteria
Inclusion Criteria for experimental group only:
- ASD diagnosis according to DSM-5 criteria and established by an interdisciplinary
Inclusion Criteria for both experimental and control groups:
- Age ≥ 18 years Age ≥ 18 years and matching typical adult subjects to ASD individuals in age (plus or minus 5 years), sex, and education level
- The person participating in the research has read, understood, and signed the study consent form
- The person is proficient in the French language
- The person is affiliated with a social security system
Exclusion Criteria for experimental group only:
- Diagnosis of any other NDD than ASD (e.g., Attention Deficit Hyperactivity Disorder, Specific Learning Disorder, Language Disorder, Coordination Disorder, Intellectual Disorder)
Exclusion Criteria for control group only:
- Diagnosis of any NDD (ASD, Attention Deficit Hyperactivity Disorder, Specific Learning Disorder, Language Disorder, Coordination Disorder, Intellectual Disorder)
Exclusion Criteria for both experimental and control groups:
- Refusal of the individual to participate in the study
- Presence of severe visual impairment
- Known pregnancy
- Individual deprived of liberty
- Individual under guardianship or curators
- Presence of concurrent psychotropic medication treatments not stabilized, initiated within the last 2 months: antipsychotics, mood stabilizers, antiepileptics, psychostimulants, antidepressants
- Presence of upper limb motor impairment, with or without devices
- Presence of diagnosed neurological or psychiatric disorders (e.g., Schizophrenia Spectrum Disorder or other psychotic disorders), presence of a general or metabolic pathology known to have an impact on cognitive efficiency and/or motor skills of the individual (e.g., Epilepsy, Tics and Tourette Syndrome, Neuro-muscular Syndrome, Metabolic Neurological Syndromes, neoplasms)
Key Trial Info
Start Date :
November 29 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06304701
Start Date
November 29 2023
End Date
May 1 2025
Last Update
March 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Niort
Niort, France, 79000